Accuracy and Safety of the Syai Tag System for Continuous Glucose Monitoring in Intensive Internal Care Unit

What this Trial Is About

Researchers are evaluating the accuracy and safety of the new Syai Tag system for continuous glucose monitoring in patients admitted to the intensive internal care unit. This study focuses on people with diabetes and other critical illnesses who need close blood sugar monitoring to prevent complications. The trial involves patients in intensive care who require blood sugar monitoring during their stay, with the aim to compare the new continuous glucose monitoring sensors against routine blood sugar tests. Participants will have two small Syai Tag sensors placed on their upper arms to continuously measure their blood sugar levels. These sensor readings will not be visible to medical staff. At the same time, healthcare professionals will carry out routine blood sugar measurements using arterial blood samples. The study will include at least 100 patients and monitor glucose levels from admission up to 14 days or until discharge. The procedure is safe, painless, and patients will continue to receive the usual standard of care. During the study, researchers will track the percentage of time the sensors function properly while in the ICU and compare the glucose values from the sensors to arterial blood gas glucose measurements. Participants will be monitored closely during their ICU stay, which is expected to last more than 24 hours. The study focuses on safety and accuracy while ensuring participants' care remains consistent throughout the trial.

Accuracy and Safety of the Syai Tag System for Continuous Glucose Monitoring in Intensive Internal Care Unit